Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT) ( DrugBank: Zidovudine, Lamivudine, Abacavir )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
325遺伝性自己炎症疾患1

325. 遺伝性自己炎症疾患


臨床試験数 : 7 薬物数 : 16 - (DrugBank : 6) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04731103
(ClinicalTrials.gov)
February 202214/7/2020Inhibition of Reverse Transcription in Type I Interferon Mediated NeuropathologyInhibition of Reverse Transcription in Type I Interferon Mediated NeuropathologyAicardi-Goutières SyndromeDrug: Abacavir (ABC);Drug: Lamivudine (3TC);Drug: Abacavir (ABC)+Lamivudine (3TC)+Zidovudine (AZT)University of EdinburghNHS Lothian;Medical Research CouncilNot yet recruiting3 Months15 YearsAll24Phase 2United Kingdom